Today, science is entering another period of accelerated change, thanks to the growth of the Internet and dawn of pervasive computing; the explosive growth of new sciences like genetic engineering, nanotechnology, biotechnology, and simulation; the rise of new scientific powers in the developing world, the revival of amateur scientists, and the growth of citizen science movements in the United States and Europe; the growth of new institutions supporting scientific research and innovation, and changes in the structure and funding of universities, government, an

SAN DIEGO, May 5 /PRNewswire/ --

- Study represents first inclusion of Volcano Revolution(R) 45 MHz IVUS Imaging Catheter in large-scale pharmaceutical plaque progression trial.

Volcano Corporation (Nasdaq: VOLC), a leading manufacturer and developer of intravascular ultrasound (IVUS), functional measurement (FM) and Optical Coherence Tomography (OCT) products designed to enhance the diagnosis and treatment of coronary and peripheral vascular disease, announced today participation in SATURN (Study of Coronary Atheroma by InTravascular Ultrasound: Effect of Rosuvastatin Versus AtorvastatiN). This marks the first major pharmaceutical trial allowing physicians to use the Volcano Revolution(R) 45 MHz IVUS Imaging catheter as part of the protocol.

Not long ago, Howard Wainer, a statistician I mentioned recently, learned that his blood sugar was too high. His doctor told him to lose weight or risk losing his sight. He quickly lost about 50 pounds, which put him below 200 pounds. He also started making frequent measurements of his blood sugar, on the order of 6 times per day, with the goal of keeping it low.

It was obvious to him that the conventional (meter-supplied) analysis of these measurements could be improved. The conventional analysis emphasized means. You could get the mean of your last n (20?) readings, for example. That told you how well you were doing, but didn’t help you do better.

Howard, who had written a book about graphical discovery, made a graph: blood sugar versus time. It showed that his measurements could be divided into three parts:

LONDON, May 5 /PRNewswire/ -- BCS Global Networks is pleased to announce that Clive Sawkins has accepted the position as Chief Executive Officer of the company. BCS is a managed service provider enabling video conferencing and visual collaboration globally. With its global video infrastructure, BCS provides its customers with an easy to use; direct connect, visual link to customers, colleagues and experts around the world.

Want to live a long life? Your genes still don't make a difference (yet) according to research on the bone health of one of the oldest persons in the world who recently died at the age of 114 The study reveals that there were no genetic modifications which could have contributed to this longevity.

The research team, directed by Universitat Autònoma de Barcelona professor Adolfo Díez Pérez, pointed out a healthy lifestyle, a Mediterranean diet, a temperate climate and regular physical activity as the reasons for his excellent health.

They studied the bone mass and analysed the genetics of a man with enviable health who at the time of the study was 113 years old. The research was carried out with four other members of his family: a 101-year-old brother, two daughters aged 81 and 77, and a nephew aged 85, all of them born and still living in a small town of the island of Menorca. The man's bones were in excellent conditions: his bone mass was normal, there were no anomalous curvatures and he had never sustained a fracture.

SINGAPORE, May 5 /PRNewswire/ -- In the news release, "Techpro Electronics Launches COPROTECTOR(TM) - The World's 1st Electrochemical Carbon Monoxide Detector Specially Designed for Use in Cars" issued on 5 May 2008 06:47 GMT, by TECHPRO ELECTRONICS PTE LTD over PR Newswire, we are advised by a representative of the company that that the following link, http://asianetnews.net/Download.asp?ID=95606 should be included at the end of the release. Complete, corrected release follows:

GENEVA, Switzerland, May 5 /PRNewswire/ --

- Longest Continuous-Treatment Prospective Study of a Biological Therapy for Psoriasis

Final results of the first three-year prospective efficacy and safety study in moderate-to-severe chronic plaque psoriasis were recently published in the British Journal of Dermatology(1). They demonstrate the sustained safety and efficacy obtained with Raptiva(R) (efalizumab) in the long-term three-year therapy of this chronic autoimmune disease.

LONDON, May 5 /PRNewswire/ --

ASDA has teamed up with Information TV to broadcast its own programme, called People, Prices, Planet, to everyone with access to Sky Digital. The documentary style programme will be broadcast daily from Tuesday May 6th on Information TV, Sky Digital channel 167 at 21.00hrs Monday to Saturday and on Sundays at 18.30hrs. ASDA is taking advantage of Information TV's innovative business model that allows organisations to broadcast their own programmes on digital television to enhance the effectiveness of their communications.

MALMO, Sweden, May 5 /PRNewswire/ -- iClin Solutions, a supplier of intelligent solutions for cancer treatment, today announced the launch of Electro Chemo Therapy - ECT - and the first treatment using the Cliniporator in Sweden. The treatment was performed at the Department of Oncology at Lund University Hospital under the supervision of Dr. Julie Gehl from Herlev Hospital in Denmark.

The Cliniporator is used to fight cutaneous and sub-cuteaneous metastasies by increasing the effect of chemotherapeutic drugs, offering a very good alternative to traditional radiation therapy and surgery.